Predictive Multiplicity in Cell-Fate Assignment: Label-Free Rashomon Sets and the Limits of Per-Cell Certification
Arjun BhupatirajuAbhiram Bhupatiraju
Oct 2026
Machine Learning
Abstract
Single-cell trajectory inference maps transcriptomic measurements onto developmental continua, yet configurations that fit the data equally well can assign conflicting cell fates. FateMultiplicity is a label-free framework that constructs a statistically admissible model set, or Rashomon set, without lineage labels, by evaluating model discrepancy on cross-fitted held-out genes under non-inferiority testing calibrated against random-seed variation. Multiplicity is large and depends more on the diversity of the model space than its size: twelve configurations of a second algorithm expose 20.0% of cells where twenty-four of the first expose 3.8%. Whether the per-cell certified fate margin FM yields more reliable assignments than the fitted model already provides is then tested, and it does not. On simulation ground truth, on the same cells, FM discriminates misassignment at AUC 0.682, against 0.965 for the baseline configuration's own decision margin (p = 0.003) and 0.854 for a seed-dispersion baseline. Informativeness is governed by the breadth of the admitted set, not its cardinality: at cardinality four, seed refits give 0.933 and hyperparameter-perturbed sets 0.701. Relaxing the infimum to a q-quantile recovers discrimination but converges toward the single model's own confidence; the supremum reaches 0.973 because theta*'s membership bounds it from below, while the infimum is unanchored. Multiplicity in trajectory inference is worth measuring and reporting, but per-cell certification over a label-free Rashomon set is not a route to more reliable fate calls. Two constructions survive: a margin-erosion ratio separates real from spurious branch points in simulation (AUC 0.890, untested on real data), and against clonally observed fate, uncertified cells disagree with their clone's outcome 16.4 percentage points more often than certified cells (p < 0.001).
This paper investigates developing real-world perception for active agents, proposes Gibson Environment for this purpose, and showcases a set of perceptual tasks learned therein.
F. Xia, Amir Zamir, Zhi-Yang He et al.· 2018 IEEE/CVF Conference on...· 1,069 citations· ⚡112
The results indicate that software engineering work practices are chosen opportunistically, adapted and configured to provide value under the constrains imposed by the startup context.
Nicolò Paternoster, Carmine Giardino, M. Unterkalmsteiner et al.· Information and Software Tec...· 394 citations· ⚡54
The possibility of inferring high-dimensional data inference in a model that consists of a prior and an auxiliary differentiable constraint given some additional information is considered, thereby allowing a range of potential applications in adapting models to new domains and tasks.
Alexandros Graikos, Esmeralda S. Whitammer, N. Jojic et al.· Neural Information Processin...· 316 citations· ⚡15
It is proved that any global minimizer of the trajectory balance objective can define a policy that samples exactly from the target distribution, and empirically demonstrate the benefits of the trajectories balance objective for GFlowNet convergence, diversity of generated samples, and robustness to long action sequenc...
Esmeralda S. Whitammer, Moksh Jain, Emmanuel Bengio et al.· Neural Information Processin...· 302 citations· ⚡60
An algorithm is proposed which leverages disentangled semantic factors to generate adversarial perturbation by altering controlled semantic attributes to fool the learner towards various "adversarial" targets.
Haonan Qiu, Chaowei Xiao, Lei Yang et al.· arXiv.org· 208 citations· ⚡17
This work proposes a HALO that directly maximizes the utility of generations instead of maximizing the log-likelihood of preferences, and suggests that the best loss depends on the inductive biases most appropriate for a given setting, an oft-overlooked consideration.
A machine-learning approach called CheMeleon provides a practical way to develop new drugs or other molecules with much less detailed, expensive experimentation.